Phio Pharmaceuticals Corporation (PHIO)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current PHIO market cap is 3.1M. The company's latest EPS is USD -12.5778 and P/E is -0.29.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.55M | -2.78M | -1.9M | -2.21M | -1.91M |
| Net Income | -2.55M | -2.78M | -1.9M | -2.15M | -1.85M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 21k | 0 | 0 | 0 | 0 |
| Operating Income | -8.99M | -8.79M | -13.51M | -11.46M | -10.82M |
| Net Income | -8.91M | -8.79M | -13.29M | -11.48M | -10.83M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 12.3M | 9.54M | 9.36M | 6.85M | 5.3M |
| Total Liabilities | 2.39M | 2.33M | 1.63M | 1.25M | 1.52M |
| Total Equity | 9.9M | 7.21M | 7.73M | 5.6M | 3.77M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 8.04M | 15.74M | 25.17M | 12.81M | 9.36M |
| Total Liabilities | 2.29M | 2.72M | 3.24M | 1.97M | 1.63M |
| Total Equity | 5.75M | 13.02M | 21.93M | 10.84M | 7.73M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -5.48M | -8.38M | -10.75M | -2.01M | -3.79M |
| Investing | -5k | -5k | -5k | N/A | N/A |
| Financing | 5.01M | 5.01M | 7.41M | -4k | -4k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -8.65M | -8.8M | -11.86M | -12.13M | -10.75M |
| Investing | -72k | -19k | -51k | -121k | -5k |
| Financing | 772k | 16.13M | 21.72M | -26k | 7.41M |
| Market Cap | 3.1M |
| Price to Earnings Ratio | -0.29 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.36 |
| Price to Book Ratio | 0.4 |
| Dividend Yield | - |
| Shares Outstanding | 860.72k |
| Average Volume (1 week) | 116.81k |
| Average Volume (1 Month) | 39.05k |
| 52 Week Change | -72.97% |
| 52 Week High | 29.07 |
| 52 Week Low | 2.40 |
| Spread (Intraday) | 0.04 (1.1%) |
| Company Name | Phio Pharmaceuticals Corporation |
| Address |
2140 s dupont hwy camden, delaware 19934 |
| Website | https://www.phiopharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
